SynDevRx
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Broadway Ste 14, Cambridge, Massachuse...Phone Number
(617) 401-3110Website
www.syndevrx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About SynDevRx
SynDevRx is a pioneering company in the field of Metabo-Oncology, focusing on transforming cancer treatment by targeting the metabolic drivers and angiogenic factors that contribute to cancer progression. Their lead compound, Evexomostat, is designed to treat cancer patients with metabolic complications and enhances the effectiveness of existing therapies. The company is currently validating its innovative approach through clinical trials, particularly in breast and prostate cancers, aiming to improve patient outcomes. SynDevRx's mission is to address the needs of an under-treated patient population across various solid tumor types.Explore more
SynDevRx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SynDevRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if SynDevRx has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on SynDevRx recently announced quarterly report
Website visits: Recent activity has been detected on your website
SynDevRx, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when SynDevRx launches new products
Congratulate Masked Content for being promoted to Masked Content at SynDevRx
Funding: Get notified immidiatlly once SynDevRx has new funding data
Click to see if SynDevRx had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if SynDevRx is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined SynDevRx as Masked Content
Find 3 more new buyers
Compare Similar Companies to SynDevRx
Compare insights from companies similar to SynDevRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
SynDevRx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
SynDevRx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about SynDevRx.
SynDevRx financials insights
Gather financial insights about SynDevRx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Unspecified
$569K
2012
Debt
$16.3M
2017
Debt
$1.5M
SynDevRx Tech Stack
A closer look at the technologies used by SynDevRx
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SynDevRx
Sign Up For FreeTo access detailed company insights
SynDevRx is a pioneering company in the field of Metabo-Oncology, focusing on transforming cancer treatment by targeting the metabolic drivers and angiogenic factors that contribute to cancer progression. Their lead compound, Evexomostat, is designed to treat cancer patients with metabolic complications and enhances the effectiveness of existing th... Read More
